Topics
Research & Innovation
-
Wednesday - May 16, 2012
Not intended for U.S. and UK media - 48th Annual Meeting of the American Society of Clinical Oncology (ASCO):
Bayer to Present Data on Late-Stage Development Oncology Compounds at ASCO 2012
First data from Phase III trial for regorafenib in gastrointestinal tumors (GIST) presented as Late-Breaking Abstract in Oral Abstract Session / Updated survival results from Phase III trial for Alpharadin (radium-223 chloride) in castration-resistant prostate cancer (CRPC) presented as Late-Breaking Abstract in Oral Abstract Session » more
-
Tuesday - April 24, 2012
Not intended for U.S. and UK media
Bayer expands targeted cancer therapy collaboration with Amgen » more
-
Wednesday - March 28, 2012
Not intended for U.S. and UK Media - 103rd Annual Meeting American Association for Cancer Research:
Bayer to Present New Data on Oncology Pipeline
New Preclinical Data Evaluating Innovative Compounds will be presented / Growing Research and Development Portfolio » more
-
Tuesday - March 27, 2012
Bayer HealthCare and Beijing’s Tsinghua University extend innovative drug discovery partnership » more
-
Thursday - February 2, 2012
Research initiative honored in Germany-wide competition
Bayer CO2 project among best ideas for the future
Pilot plant in Leverkusen is one of the “Selected Landmarks 2012” / Innovative process for producing plastics with carbon dioxide » more
-
Monday - January 9, 2012
Bayer HealthCare to Share Lab Space with Start-Up Companies
Dedicated lab space-model at Bayer HealthCare U.S. Innovation Center to be called CoLaborator™ / Shared lab space will help promising life science companies get their start » more
-
Monday - December 19, 2011
Awards from the Bayer Science & Education Foundation:
Bayer Early Excellence in Science Award 2011: EUR 30,000 for young research scientists
Dr. Cristobal Uauy (John Innes Centre in Norwich, Great Britain) wins the „Biology“ category / Dr. Andreas Bender (University of Cambridge, Great Britain) takes the „Chemistry“ award / Prof. Dr. Arne Thomas (Technical University Berlin) awarded prize in the „Materials“ field » more
-
Thursday - November 17, 2011
New edition of research, the Bayer scientific magazine
Innovations from the world of research at Bayer
Personalized medicine against cancer / Creating new active crop protection ingredients with biotechnology / Electric mobility: materials for the cars of the future » more
-
Wednesday - November 9, 2011
Bayer cooperates with Ludwig Boltzmann Institute for Translational Heart Failure Research
Newly founded institute studies the causes of heart failure and seeks new therapeutic options » more
-
Wednesday - October 26, 2011
Not intended for U.S. and UK media
Phase III Trial of Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival
Trial stopped based on positive data from a pre-planned interim analysis » more
-
Friday - October 7, 2011
Successful partnership with TU Dortmund University
Bayer Technology Services honors outstanding graduates in biochemical and chemical engineering » more
-
Saturday - September 24, 2011
Not intended for U.S. and UK Media: Results of Phase III study in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases:
Positive Phase III Data on Bayer’s Investigational Drug Alpharadin Show Significant Increase in Overall Survival
First presentation of full data as part of Presidential Session featuring best and late-breaking abstracts at 2011 European Multidisciplinary Cancer Congress » more
-
Wednesday - September 21, 2011
Factory of the future
Bayer and TU Dortmund University open the INVITE research center
Managing Director Dr. Thomas Bieringer presents new concept for production of active ingredients » more
-
Friday - September 16, 2011
Bayer Science & Education Foundation:
EUR 200,000 for scholarships and teacher training
Promotion of ambitious study projects and international work experience / Emphasis on natural sciences and medicine / Hermann Strenger scholarships for career training / About EUR 938,000 already provided to support 177 young people since 2007 » more
-
Thursday - September 15, 2011
Propelling growth across the value-chain from seed-to-shelf:
Bayer CropScience presents new four pillar growth strategy: Focus on portfolio conversion, value chain, BioScience and innovation
Investment in BioScience research to double by 2015 / Accelerated portfolio conversion: Phase-out of WHO Class I products by end of 2012 » more
-
Wednesday - September 7, 2011
Superior effectiveness for more nights of protection:
LifeNet® exceeds WHOPES requirements » more
-
Tuesday - August 23, 2011
Not intended for U.S. Media
FDA Grants Fast Track Designation to Bayer’s Investigational Compound Alpharadin™ for the Treatment of Castration Resistant Prostate Cancer in Patients with Bone Metastases » more
-
Thursday - June 30, 2011
Bayer advances research in the area of pulmonary hypertension
Cooperation with the Ludwig Boltzmann Institute for Lung Vascular Research / The aim is to develop new treatment options for patients with pulmonary hypertension » more
-
Monday - June 27, 2011
Cooperation with leading European seed company:
Bayer CropScience and RAGT Semences sign licensing and cooperation agreement for the improvement of wheat » more
-
Thursday - June 16, 2011
Bayer Science & Education Foundation launches new round of funding
Bayer foundation scholarships – EUR 200,000 for work and study abroad
Support for ambitious study projects in the fields of science, engineering, medicine and teacher training in scientific subjects / First award of Hermann Strenger scholarships to sponsor career-training projects abroad / Applications now possible online till July 15, 2011 » more
Copyright @ Bayer AG
Search
Publications
Newsletter
Events
Download Center - Selection
